Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Share Price
Equities
603392
CNE100004090
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.15 CNY | -1.93% |
|
-9.61% | -12.88% |
| 28/04 | Wantai Biological Pharmacy Narrows Q1 Loss; Shares Fall 3% | MT |
| 27/04 | Beijing Wantai Biological Pharmacy Enterprise Q1 net loss at 43.0 million yuan | RE |
| Capitalization | 4.95TCr 726.75Cr 626.82Cr 574.2Cr 542.58Cr 1TCr 70TCr 1.03TCr 6.84TCr 2.66TCr 33TCr 2.73TCr 2.67TCr 1,15700Cr | P/E ratio 2026 * |
-149x | P/E ratio 2027 * | -190x |
|---|---|---|---|---|---|
| Enterprise value | 4.95TCr 726.75Cr 626.82Cr 574.2Cr 542.58Cr 1TCr 70TCr 1.03TCr 6.84TCr 2.66TCr 33TCr 2.73TCr 2.67TCr 1,15700Cr | EV / Sales 2026 * |
25.9x | EV / Sales 2027 * | 22.5x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.93% | ||
| 1 week | -9.61% | ||
| Current month | -0.38% | ||
| 1 month | -1.29% | ||
| 3 months | -2.51% | ||
| 6 months | -27.03% | ||
| Current year | -12.88% |
| 1 week | 38.82 |  | 42.38 |
| 1 month | 38.27 | | 46.98 |
| Current year | 37.85 | | 48.77 |
| 1 year | 37.85 | | 80 |
| 3 years | 37.85 | | 89.89 |
| 5 years | 37.85 | | 147.67 |
| 10 years | 4.43 | | 147.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhiming Jiang
CEO | Chief Executive Officer | 53 | 15/01/2024 |
Hao Chen
ADM | Chief Administrative Officer | 44 | 01/01/2007 |
Shu Ling Zhao
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Xin Qiu
CHM | Chairman | 62 | 13/01/2021 |
Qing Chao Xing
CHM | Chairman | 41 | 13/04/2018 |
Zhi Gang Zhao
BRD | Director/Board Member | 48 | 05/05/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.93% | -9.61% | -42.78% | -44.46% | 741.42Cr | |
| +0.10% | -12.87% | +5.66% | -16.96% | 6.41TCr | |
| +2.17% | -2.65% | +47.04% | +166.09% | 5.09TCr | |
| -2.89% | +34.60% | +34.60% | +34.60% | 4.29TCr | |
| -0.77% | -0.97% | -59.91% | -68.16% | 3.34TCr | |
| -0.70% | -4.41% | +47.22% | -38.23% | 2.83TCr | |
| -4.97% | -14.17% | +73.25% | -63.78% | 1.91TCr | |
| +0.43% | -3.56% | +49.82% | +50.39% | 1.9TCr | |
| -1.94% | -9.99% | +41.68% | +101.67% | 1.78TCr | |
| +0.05% | -1.09% | +40.58% | +82.06% | 1.6TCr | |
| Average | -1.07% | -6.49% | +23.72% | +20.32% | 2.99TCr | |
| Weighted average by Cap. | -0.64% | -6.76% | +23.41% | +26.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 191.35Cr 28Cr 24Cr 22Cr 21Cr 39Cr 2.72TCr 40Cr 264.51Cr 103.01Cr 1.28TCr 105.42Cr 103.17Cr 4.47TCr | 219.63Cr 32Cr 28Cr 25Cr 24Cr 44Cr 3.12TCr 45Cr 303.6Cr 118.23Cr 1.47TCr 121Cr 118.42Cr 5.13TCr |
| Net income | -33Cr -4.9Cr -4.23Cr -3.87Cr -3.66Cr -6.75Cr -474.48Cr -6.92Cr -46Cr -18Cr -223.36Cr -18Cr -18Cr -779.96Cr | -26Cr -3.84Cr -3.31Cr -3.03Cr -2.87Cr -5.29Cr -371.8Cr -5.42Cr -36Cr -14Cr -175.03Cr -14Cr -14Cr -611.18Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 39.15 ¥ | -1.93% | 46,09,271 |
| 18/26/18 | 39.92 ¥ | +0.91% | 38,85,709 |
| 15/26/15 | 39.56 ¥ | -1.17% | 53,33,494 |
| 14/26/14 | 40.03 ¥ | -4.71% | 82,48,604 |
| 13/26/13 | 42.01 ¥ | -3.00% | 92,93,796 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603392 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition